Record PAT masked by one-time gain; input headwinds emerge
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Met FY26 guidance on outperformance and auto growth rates. Near-term margin guidance at risk given 100 bps QoQ compression despite pricing actions.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
SJS delivered record revenue and adjusted PAT growth of 45%, but headline PAT is 32% inflated by ₹241.7 Cr one-time facility sale gain. Core business momentum is solid (27 quarters of outperformance, strong export growth 83% YoY), but margin guidance of 27-28% is now at risk: EBITDA margin contracted 100 bps QoQ to 30% despite pricing claims, with 50-60 bps input cost headwind still only partially recovered. Long-term upside hinges on unproven ramps (BOE display from Q2 FY28, Decoplast 3-4 year ramp) with execution and margin profile TBD.
₹261 Cr
Revenue · +24.5% YoY₹74.4 Cr
Reported PAT · +115% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Highest-ever quarterly revenue and profitability since listing
OVERSTATED₹261 Cr revenue, ₹74.4 Cr PAT confirmed; however ₹241.7 Cr (32.5% of PAT) is one-time gain from old Bangalore facility sale
115% YoY PAT growth with strong operational performance
MISSAdjusted PAT excluding one-time gain is ₹50.3 Cr, +45.2% YoY; core operating profit growth is healthy but PAT headline inflated
EBITDA margin improved to 30% on product mix and export contribution
MISS30% EBITDA margin down ~100 bps QoQ from ~31% in Q4 FY26; despite pricing pass-through, input cost headwind of 50-60 bps was absorbed via operational efficiency, not margin expansion
Outperformed industry by 32.4% auto growth vs 21.7% industry growth (1.5x)
MET32.4% SJS auto growth vs 21.7% combined PV+2W industry is confirmed; sustained 27th consecutive quarter of outperformance is plausible
Gross margin stable despite inflation; pricing already being passed to customers
PartialQ4 56.6% vs Q1 56.7% gross margin (up only 0.1% QoQ). Pricing pass-through is in progress but lagged 1-2 quarters; only partial recovery visible
Earnings quality
What changed since the last call
Margin guidance reaffirmed despite QoQ compression
Neutral27-28% EBITDA margin guidance held despite 100 bps QoQ decline to 30% this quarter. Management cited new product ramp as offset but no numeric target revised. Prudent but cautious.
Export target reaffirmed at 14-15% by FY28
NeutralCurrently 9.8% of revenue; growing 83% YoY. Management confident on 'large businesses under discussion' but no firm orders disclosed vs prior call. Timeline held.
BOE display timeline on track but unvalidated
NeutralPlant commissioning Q2 FY28 as guided. Production samples at BOE for OEM field testing. No customer orders or ramp assumptions given; margin profile TBD pending manufacturing cost validation.
Decoplast capacity expansion accelerated; new facility commissioned Aug 2026
UpgradePune facility adds 200-250 Cr revenue capacity over 3 years; expect 85-90% utilization by year 3, 2-2.5x asset turn. Breakeven at 1-1.25x asset turn (likely Q2-3 of FY27).
The Q&A
Analysts pressed hard on margin sustainability (Chandramouli-Goldman Sachs): questioned 200 bps gross margin decline and timeframe to pass costs to customers. Management held line but selectively: admitted 50-60 bps input headwind, held pricing recovery is 1-2 quarter lagged. Analysts also sceptical on BOE display timing and exclusivity vs Pricol (Amit Jain). Management credibly clarified: 4-wheeler focus (larger market, higher margin) vs Pricol's 2-wheeler, and has exclusivity for 4-wheelers. Tone was confident but not dismissive of concerns.
Margin management and input costs — Chandramouli, Goldman Sachs
PartialMargins have improved, not declined. Gross margin Q4 56.6% vs Q1 56.7%, up 10 bps. Input cost headwind ~50-60 bps offset by richer product mix, export contribution, operational efficiency. Customer pricing negotiations ongoing; some wins already in place, some lagged 1-2 quarters.
Decoplast capacity utilization and returns — Chandramouli, Goldman Sachs
AnsweredAsset turn 2-2.5x at steady state (company-wide average >2x). Utilization 85-90% in 3 years. Breakeven at 1-1.25x asset turn (likely near end of FY27 or Q1 FY28). Order book very strong, bullish on prospects.
Cover glass and display business with BOE — Pranay Roop Chatterjee, Burman Capital
AnsweredEquipment on order, will ship and install. Sales start Q2 FY28 from new plant. Technical license with BOE; development samples currently with OEMs for testing. Orders expected after plant PPAP validation. Subsidiary structure leaves door open for JV if BOE wants to expand.
BOE supply chain and competitive positioning — Pranay Roop Chatterjee, Burman Capital
AnsweredBOE handles global development and prototyping; SJS handles India localization and assembly. Tripartite conversations (customer, BOE, SJS) on India supply timing. BOE leads technical phase, SJS executes local. This is exactly the model being followed.
Exports and Walter Pack growth — Pranay Roop Chatterjee, Burman Capital
PartialMultiple large businesses under discussion, good pipeline. Target still 14-15% exports by FY28. Advanced stage discussions happening across multiple technologies and geographies. Typical ramp during course of FY27. On track.
Cover glass TAM and margin expectations — Nitin Agrawal, JM Financial
PartialDisplay market (of which cover glass is part) currently ₹500-1000 Cr, expected to grow to ₹5000-7000 Cr by 2030. SJS aspiration: 10% market share by 2030. Margins higher than assembly margins; TBD when manufacturing starts. 50% of display is TFT (imported from BOE), 50% localized by SJS.
PV segment QoQ revenue decline — Pooja Sheth, YES Securities
AnsweredIndustry 4-wheeler segment declined 7.5% QoQ (Q4 to Q1). This is normal seasonality; Q1 soft period, demand picks up before festive sales in Q2. SJS PV grew 45.3% YoY. Strong overall.
EV content opportunity and two-wheeler prospects — Akshaj, Ashika Investment Managers
PartialLocalization of display/instrument cluster is the key; currently many Indian OEMs import from overseas. As EV volumes grow, investment in India localization will increase. Cover glass is additional opportunity. Volumes still low but growing rapidly; big lever for future growth.
Walter Pack Spain non-compete and export opportunity — Aditya Dayal, Zeva Consultants
AnsweredNon-compete till January 2027. Prefer cooperative agreement; Walter Pack Spain may not have capacity for everything. Could leverage partnership to co-operate. Theoretically can supply BMW, Audi, but till Jan 2027 cannot compete with Walter Pack Spain on these accounts.
Long-term growth outlook to 2030 — Nalin Shah, NVS Brokerage
PartialExtremely bullish. All building blocks in place (capacity, cash generation). By 2030 expect organic and inorganic growth. Exports major chunk of journey. Intentionally maximizing sales.
Walter Pack India capex and revenue targets post-utilization — Khush, Electrum PMS
DodgedWalter Pack operating at 75% capacity. Developing couple of new businesses. No immediate capex beyond normal maintenance. Will disclose further capex plan in future.
Guidance
FY27 outperform industry by 1.5x-2x; supported by order book covering 85%+ of forecast
High27 quarters of track record; automotive business 32.4% YoY growth vs 21.7% industry this quarter validates assumption
Sustain long-term EBITDA margins 27-28%; gated by new product ramp and premium mix
MediumQ1 EBITDA 30% down 100 bps QoQ; input costs 50-60 bps headwind not fully offset yet. New generation products 24% of revenue; upside contingent on volume.
Significant capacity expansions at Decoplast (₹200-250 Cr revenue over 3-4 years) and cover glass facility (Q2 FY28 start)
HighDecoplast Pune facility commissioned Aug 2026; breakeven at 1-1.25x asset turn. Cover glass equipment on order, PPAP runs to start when plant ready.
Risks the call surfaced
Margin compression from input inflation
MediumInput costs created 50-60 bps headwind Q1 FY27; pricing pass-through lagged 1-2 quarters. If recovery stalls, 27-28% EBITDA margin guidance at risk.
BOE display facility execution and timeline
MediumCover glass and display facility ramp-up dependent on BOE's global supply chain, customer approvals, and PPAP validation. No firm customer orders disclosed. Margin profile TBD. Delays could push revenue recognition to FY29.
Decoplast capacity absorption and timeline
MediumNew Pune facility adds 1.75x existing capacity with target 85-90% utilization over 3 years. Revenue ramp of ₹200-250 Cr over 3-4 years is contingent on order flow and export execution. Utilization slippage would hurt ROCE.
Automotive industry growth assumption
MediumFY27 guidance assumes automotive industry growth of 21.7% (passenger vehicle + 2-wheeler combined). If macro softens, SJS 1.5x-2x outperformance assumption may not hold. Industry growth has been lumpy; macro uncertainty (interest rates, consumer demand, supply chain).
Walter Pack new business ramp delay
LowNew businesses at Walter Pack have been 'under discussion' for 2+ quarters with tooling timelines repeatedly pushed. Revenue contribution still unclear; management non-committal on timing or magnitude.
Management
Score 7/10. Clear and transparent on numbers; disclosed one-time gain explicitly and provided adjusted PAT for comparability. Selective on future timelines (BOE margin, Walter Pack orders, Decoplast ramp); cites confidentiality but leaves gaps. 27 consecutive quarters of outperformance vs industry tracked and verified. Q1 FY27 revenue and adjusted PAT growth (45.2%) in line with expectations. Capacity expansion executed on schedule (Pune facility Aug 2026). Margin guidance held despite headwinds; prudent conservatism.
1 · Q2 FY28
SJS cover glass/display facility production ramp; BOE supplies test samples to OEM customers for validation
2 · FY27 full year
Walter Pack new business launch post-tooling completion; exports growth acceleration toward 14-15% target
3 · 3-4 years
Decoplast capacity addition of ₹200-250 Cr revenue, expected 85-90% utilization by year 3
Long-term upside hinges on unproven ramps (BOE display from Q2 FY28, Decoplast 3-4 year ramp) with execution and margin profile TBD.
Informational and educational content only. Not investment advice.